Brief: Biosergen Q3 EBITDA SEK -12.19 Million
19/11/2025 07:31
Nov 19 (Reuters) - Biosergen Q3 EPS SEK -0.05. Q3 adjusted EBIT SEK -12.19 million Q3 net income SEK -12.168 million
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million